Related references
Note: Only part of the references are listed.Herpes simplex virus 1 infection on grey matter and general intelligence in severe mental illness
Dimitrios Andreou et al.
TRANSLATIONAL PSYCHIATRY (2022)
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Dharma Rao Tompa et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Infections of the central nervous system as a risk factor for mental disorders and cognitive impairment: A nationwide register-based study
Emilie M. J. Pedersen et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Purinergic signaling in infectious diseases of the central nervous system
Vinicius Santos Alves et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
Zhiliang Hu et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Balancing the risks to individual and society: a systematic review and synthesis of qualitative research on antibiotic prescribing behaviour in hospitals
E. M. Krockow et al.
JOURNAL OF HOSPITAL INFECTION (2019)
Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis
Anneleen Berende et al.
NEUROLOGY (2019)
Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
Stephen S. Dominy et al.
SCIENCE ADVANCES (2019)
Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases
Justine Renaud et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study
Alan Breier et al.
SCHIZOPHRENIA RESEARCH (2019)
Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease
John W. Gnann et al.
EMERGING INFECTIOUS DISEASES (2019)
Treatment of PANDAS and PANS: a systematic review
Sofia Sigra et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan
Nian-Sheng Tzeng et al.
NEUROTHERAPEUTICS (2018)
A DOUBLE-BLIND TRIAL OF VALACYCLOVIR TO IMPROVE COGNITION IN EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE VISTA STUDY
Alan Breier et al.
SCHIZOPHRENIA BULLETIN (2018)
Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment
Triptish Bhatia et al.
SCHIZOPHRENIA RESEARCH (2018)
The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
Nour Yahfoufi et al.
NUTRIENTS (2018)
Dysfunctional Emotion Discrimination in Schizophrenia is Associated with HSV-1 Infection and Improves with Antiviral Treatment
Vishwajit Nimgaonkar et al.
BIOLOGICAL PSYCHIATRY (2017)
N-methyl-D-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis
G. Westman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Asher Brauner et al.
NATURE REVIEWS MICROBIOLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Small studies are more heterogeneous than large ones: a meta-meta-analysis
Joanna IntHout et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
The Association between Infections and General Cognitive Ability in Young Men - A Nationwide Study
Michael Eriksen Benros et al.
PLOS ONE (2015)
Persistent Viral Pathogens and Cognitive Impairment Across the Life Course in the Third National Health and Nutrition Examination Survey
Kara D. Tarter et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study
Renee Donahue Carlson et al.
METABOLIC BRAIN DISEASE (2014)
Antiherpes Virus-Specific Treatment and Cognition in Schizophrenia: A Test-of-Concept Randomized Double-Blind Placebo-Controlled Trial
Konasale M. Prasad et al.
SCHIZOPHRENIA BULLETIN (2013)
The Impact of Inflammation on Cognitive Function in Older Adults: Implications for Healthcare Practice and Research
Andrea C. Sartori et al.
JOURNAL OF NEUROSCIENCE NURSING (2012)
The MATRICS Consensus Cognitive Battery (MCCB): Clinical and cognitive correlates
Sharon M. August et al.
SCHIZOPHRENIA RESEARCH (2012)
Bias modelling in evidence synthesis
Rebecca M. Turner et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy
B. A. Fallon et al.
NEUROLOGY (2008)
Dexamethasone and long-term outcome in adults with bacterial meningitis
Martjn Weisfelt et al.
ANNALS OF NEUROLOGY (2006)
Impairment in the specificity of emotion processing in schizophrenia
F Schneider et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A systematic review of prion therapeutics in experimental models
Clare R. Trevitt et al.
BRAIN (2006)
Efficacy of flupirtine on cognitive function in patients with CJD - A double-blind study
M Otto et al.
NEUROLOGY (2004)
Cognitive function in post-treatment Lyme disease - Do additional antibiotics help?
RF Kaplan et al.
NEUROLOGY (2003)
Study and treatment of post Lyme disease (STOP-LD) - A randomized double masked clinical trial
LB Krupp et al.
NEUROLOGY (2003)
Computerized neurocognitive scanning: II. The profile of schizophrenia
RC Gur et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Share Paper
